Specific peptides for the therapeutic targeting of oncogenes
- 28 February 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 16 (1) , 71-77
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Current strategies for the development of peptide‐based anti‐cancer therapeuticsJournal of Peptide Science, 2005
- TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cellsDNA Repair, 2005
- Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2)Cancer Research, 2004
- Transduction peptides: from technology to physiologyNature Cell Biology, 2004
- Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating PeptidePLOS Biology, 2004
- ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoproteinBlood, 2004
- Can transcription factors function as cell–cell signalling molecules?Nature Reviews Molecular Cell Biology, 2003
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator proteinCell, 1988